Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis

Asselah T, Bourgeois S, Pianko S, Zeuzem S, Sulkowski M, Foster GR, et al. Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis. Liver International: Official Journal of the International Association for the Study of the Liver. 2018;38(3):443 - 450.

Publication Type:

Journal Article

Source:

Liver International: Official Journal of the International Association for the Study of the Liver, Volume 38, Issue 3, p.443 - 450 (2018)

Keywords:

Antiviral Agents, Direct-acting antivirals, NS5A inhibitor, Polymerase inhibitor
Top